Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Free Cash Flow came in at -$41.0 million in Q1 2026, down 39.54% YoY from -$67.7 million in Q1 2025, and down 3.88% on a QoQ basis from -$39.4 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Free Cash Flow data on file, last reported at -$41.0 million in Q1 2026.

  • Quarterly Free Cash Flow fell 39.54% year-over-year to -$41.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.1 million (down 37.91% YoY) and the FY2025 annual result came in at -$136.5 million, down 16.01% from the prior year.
  • Free Cash Flow fell to -$41.0 million in Q1 2026, from -$39.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$21.3 million in Q3 2024 to a low of -$63.4 million in Q2 2022.
  • A 5-year average of -$43.2 million and a median of -$39.6 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow slumped 69.04% — and 2024, when it jumped 49.48%.
  • Tracing KOD's Free Cash Flow over 5 years: stood at -$58.2 million in 2022, then dropped by 2.65% to -$59.7 million in 2023, then jumped by 49.48% to -$30.2 million in 2024, then plunged by 30.64% to -$39.4 million in 2025, then retreated by 3.88% to -$41.0 million in 2026.
  • The last three Free Cash Flow figures came in at -$41.0 million (Q1 2026), -$39.4 million (Q4 2025), and -$32.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -46.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.59 Mn
Mar 31, 2026 -40.95 Mn
Dec 31, 2025 -39.42 Mn
Sep 30, 2025 -32.89 Mn
Jun 30, 2025 -34.83 Mn
Mar 31, 2025 -29.37 Mn
Dec 31, 2024 -30.19 Mn
Sep 30, 2024 -21.33 Mn
Jun 30, 2024 -26.55 Mn
Mar 31, 2024 -39.62 Mn
Dec 31, 2023 -59.74 Mn
Sep 30, 2023 -32.99 Mn
Jun 30, 2023 -43.43 Mn
Mar 31, 2023 -59.39 Mn
Dec 31, 2022 -58.18 Mn
Sep 30, 2022 -61.36 Mn
Jun 30, 2022 -63.37 Mn
Mar 31, 2022 -60.62 Mn
Dec 31, 2021 -67.47 Mn
Sep 30, 2021 -56.78 Mn